Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Decoding the Molecular Logic of GPCR Signaling

Project description

Decoding GPCR signalling at the single-molecule level

G protein-coupled receptor (GPCR) signalling is central to human health, yet its molecular logic remains poorly understood. The ERC-funded SignAlloMod project aims to close this gap by developing a novel single-molecule approach to quantitatively decode key allosteric phenomena in GPCR signalling, including ligand efficacy, biased signalling and allosteric modulation. By establishing a workflow that integrates biophysics, microfluidics and quantitative modelling, SignAlloMod will create an experimental framework for studying GPCRs at the single-molecule level. The project will investigate three model receptors, enabling the separation of ligand- and transducer-specific effects. Expected outcomes include a validated platform for measuring GPCR binding and conformational dynamics, the generation of quantitative ligand profiles and the development of new principles for designing pathway-selective drugs guided by physical models.

Objective

G protein-coupled receptors (GPCRs) are key to human physiology and disease, yet their signaling remains enigmatic. What we do know is that GPCRs signal by means of allosteric communication across the cell membrane, acting as logic gates that relay signals from extracellular ligands to various intracellular transducers. Nonetheless, the logic underlying GPCR signaling at the molecular level is not yet understood. This is particularly true of three key signaling phenomena: ligand efficacy, biased signaling, and allosteric modulation. In SignAlloMod, we will address this challenge and investigate the logic of transmembrane signaling through GPCRs at the single-molecule level. We will develop a new single-molecule microfluidic method that enables simultaneous measurement of transducer binding and receptor activation states, making rigorous, quantitative models of GPCR allostery experimentally accessible. This will allow us to separate, for the first time, ligand-specific from transducer-specific effects in GPCR signaling, ultimately enabling us to decode the molecular logic of GPCR signaling. We will use prototypical GPCRs to establish our approach and to study ligand efficacy, biased signaling, and allosteric modulation. The quantitative insights into ligand-specific and transducer-specific effects afforded by SignAlloMod will redefine our understanding of GPCR signaling. SignAlloMod will provide pharmacological ligand profiles with unprecedented detail, opening new horizons for drug discovery and pharmacological intervention guided by physical principles.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2024-STG

See all projects funded under this call

Host institution

UNIVERSITAET GRAZ
Net EU contribution
€ 1 499 389,00
Address
UNIVERSITATSPLATZ 3
8010 Graz
Austria
Region
Südösterreich Steiermark Graz
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 499 389,00

Beneficiaries (1)